Trials / Completed
CompletedNCT02476201
Quartet Lead and Resynchronization Therapy Options III (QUARTO_III)
Quartet Lead and Resynchronization Therapy Options - Assessing the Response Rate at 6 Months in CRT Patients Implanted With a Quartet Left Ventricular(LV) Quadripolar Lead and the MultiPoint Pacing (MPP) Feature Activated
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 105 (actual)
- Sponsor
- Abbott Medical Devices · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the study is to assess prospectively at 6 months the percentage of responder patients implanted with a Cardiac Resynchronization Therapy (CRT-D) device and a Quartet Left Ventricular (LV) quadripolar lead and with the MultiPoint Pacing (MPP) feature activated.
Detailed description
The primary endpoint of the study is to measure prospectively at 6 months the percentage of responder\* patients implanted with a Quartet LV quadripolar lead and with the MultiPoint Pacing feature activated compared with No Pacing at baseline. \*A positive CRT response is defined as an improvement of more than 15 % in Left Ventricular End Systolic Volume (LVESV) at 6 months post-implant, measured by Echocardiography.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | MPP ON | Patients implanted with a Cardiac Resynchronization Therapy CRT-D device and a Quartet Left Ventricular (LV) quadripolar lead and with the MultiPoint Pacing (MPP) feature activated |
Timeline
- Start date
- 2016-02-01
- Primary completion
- 2019-02-13
- Completion
- 2019-07-01
- First posted
- 2015-06-19
- Last updated
- 2022-03-02
- Results posted
- 2020-08-03
Locations
1 site across 1 country: Spain
Source: ClinicalTrials.gov record NCT02476201. Inclusion in this directory is not an endorsement.